Fresh Equities
CSL LIMITED

CSL LIMITED

ASX:CSL

Biotechnology

Live Capital Raise

CSL LIMITED has not announced a capital raise, but we are collating interest in any future round. Pledge your support and we will let the company know of your interest.

Demand Registered for Next Raise
< $50k
Investors Interested in Next Raise
< 10

Capital Raise History


Company Overview

CSL Limited (CSL) is a global biotechnology company that develops and delivers innovative medicines that save lives, protect public health and help people with life-threatening medical conditions live full lives. The operational businesses include CSL Behring and Seqirus. The Group operates predominantly in Australia, the USA, Germany, the United Kingdom and Switzerland.

Type

Listed Company

GICS Sub-industry

Biotechnology

Head Office

45 Poplar Rd, Parkville VIC 3052, Australia

Biotechnology
Health Care

Quarterly Cash Flows
The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Directors


Announcements, Interviews, News, and Presentations


More Companies Raising Right Now


Other Companies You Might Like

Fresh Equities

Copyright © 2018 Fresh Equities. All rights reserved.

ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Archive

Support

This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by Fresh Equities Pty Ltd, its representatives or any other third party regardless of whether such security, product or service is referenced on this website.